Glenmede Trust CO Na Chimerix Inc Transaction History

Glenmede Trust CO Na

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$2.43 - $5.42 $16,990 - $37,896	-6,992 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.24 - $3.9 $15,662 - $27,268	6,992 New	6,992 $17,000
Q3 2018 Nov 15, 2018	SELL	$3.58 - $4.9 $25,031 - $34,260	-6,992 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.25 $30,415 - $36,708	6,992	6,992 $0

37M

52.7K

130K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $78.9M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.